In particular, the role of macrophage activation in the context of Stamp2 deficiency was reported in various pathologies like atherosclerosis (14), pulmonary hypertension (15), adipose tissue insulin resistance (36) and prostate cancer (37). Here, STEAP4 is linked to pulmonary hypertension.